KOL VIDEO HIGHLIGHTS Apremilast as an Off-Label Therapeutic Agent

Reviewed By: Editorial Board

In this video, Mark Lebwohl, MD discusses a recent article: Apremilast as an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses

More KOL Highlights From this Issue

VIDEO HIGHLIGHTS
Smoke Evacuation in Dermatology: A National Cross-Sectional Analysis Examining the Behaviors and Perceptions of Dermatologists and Dermatologic Surgeons